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OBJECTIVE: To evaluate the prognostic value of platelet counts in acute kidney injury patients requiring renal
replacement therapy.
METHODS: This prospective cohort study was performed in three tertiary-care hospitals. Platelet counts were
obtained upon admission to the intensive care unit and during the first week of renal replacement therapy on
days 1, 3, 5 and 7. The outcome of interest was the hospital mortality rate. With the aim of minimizing
individual variation, we analyzed the relative platelet counts on days 3, 5, 7 and at the point of the largest
variation during the first week of renal replacement therapy. Logistic regression analysis was used to test the
prognostic value of the platelet counts.
RESULTS: The study included 274 patients. The hospital mortality rate was 62%. The survivors had significantly
higher platelet counts upon admission to the intensive care unit compared to the non-survivors [175.56103/
mm3 (108.5–2596103/mm3) vs. 1486103/mm3 (8021416103/mm3)] and during the first week of renal
replacement therapy. The relative platelet count reductions were significantly associated with a higher
hospital mortality rate compared with the platelet count increases (70% vs. 44% at the nadir, respectively). A
relative platelet count reduction .60% was significantly associated with a worse outcome (mortality
rate = 82.6%). Relative platelet count variations and the percentage of reduction were independent risk
factors of hospital mortality during the first week of renal replacement therapy.
CONCLUSION: Platelet counts upon admission to the intensive care unit and at the beginning of renal
replacement therapy as well as sequential platelet count evaluation have prognostic value in acute kidney
injury patients requiring renal replacement therapy.
KEYWORDS: Platelets; Acute Kidney Injury; Mortality; Prognosis; Intensive Care Unit.
Valente C, Soares M, Rocha E, Cardoso L, Maccariello E. The evaluation of sequential platelet counts has prognostic value for acute kidney injury
patients requiring dialysis in the intensive care setting. Clinics. 2013;68(6):803-808.
Received for publication on January 29, 2013; First review completed on February 16, 2013; Accepted for publication on February 16, 2013
E-mail: emaccariello@yahoo.com.br
Tel.: 55 21 2249-9131
& INTRODUCTION
Acute kidney injury (AKI) is a frequent complication in
patients admitted to the intensive care unit (ICU) and is
associated with high mortality rates, particularly when renal
replacement therapy (RRT) is required (1). In this setting,
the outcomes for AKI patients are mainly related to indivi-
dual characteristics, such as older age, the number of organs
in failure, the presence of co-morbidities, reduced functional
capacity and the severity of their acute illness (1–4).
Recently, low platelet counts (PCs) have been recognized
as a prognostic marker in the ICU (5,6). Significantly low
initial thrombocytopenia (PC,506103/mm3) has been
shown to predict higher mortality rates in community-
acquired pneumonia as well as in surgical and medical ICU
patients (7–9). Moreover, sequential PC evaluations have
been identified as an independent mortality risk factor (10).
In advanced renal failure with uremia, the PC is usually
normal or slightly reduced (11). Although 16% to 55% of
end-stage renal disease patients may present with throm-
bocytopenia, values under 1006103/mm3 are infrequent
without a superimposed cause (12,13). In AKI, however, a
low PC has been recognized as a prognostic marker (6,14).
Moreover, severe thrombocytopenia at the beginning of
RRT has been associated with hospital mortality (14).
PC measurements are simple, low-cost, usually obtained
daily and associated with ICU and hospital mortality rates.
However, the prognostic value of the PC and an assessment
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of its over-time variations in patients requiring RRT in the
ICU have not been completely elucidated. Therefore, the
aim of the present study was to evaluate the prognostic
value of the PC and its sequential evaluation in AKI patients
during the first week of RRT.
& PATIENTS AND METHODS
This prospective cohort study was conducted from
January 2007 to December 2009 in nine medical and surgical
ICUs at three tertiary-care hospitals in Rio de Janeiro, Brazil.
The study was approved by the ethics committees of the
participating institutions without the need for informed
consent because this was an observational study.
Patients’ characteristics
All of the AKI patients who needed RRT during the first
week of ICU admission were included. End-stage renal
disease patients on chronic dialysis and patients within
,24 h of admission to the ICU were excluded. AKI was
classified according the Risk, Injury, Failure, Loss and End-
stage renal disease (RIFLE) criteria immediately before the
start of RRT. Decisions to start, change the method of, and
stop RRT were made together by the nephrologists and
intensivists individually responsible for the patients. The
same team of nephrologists managed the patients in all of the
participating ICUs. The prescribed RRT modalities were
daily conventional dialysis (daily-IHD), prolonged intermit-
tent RRT (PIRRT) and continuous RRT (CRRT) according to
the patient’s hemodynamic status (R.I.O.S. allocation system)
(4). CRRT was employed in patients receiving vasoactive
drugs and in patients with the potential for hemodynamic
and neurologic instabilities. The RRT procedures were
performed using DIAPACT (B. Braun, Melsungen,
Germany), and the intermittent procedures were performed
using AK200 series (Gambro, Lund, Sweden) machines.
Polysulfone (PS, Fresenius, Frankfurt, Germany) mem-
branes, customized bicarbonate solutions and a blood flow
rate of 200 to 300 ml/min were prescribed in each dialysis
procedure. When anticoagulation was needed, low molecu-
lar weight (LMW) heparin was prescribed. Demographic,
clinical and laboratory data were prospectively collected.
The previous comorbidities [Charlson index and chronic
health status (Knaus)] (15,16), main diagnosis for ICU
admission, pre-morbid renal function, need for mechanical
ventilation or vasopressors for more than 24 h, contributing
factors for AKI and severity of the acute illness [SAPS II (17)
and SOFA (18)] were also recorded.
Platelet Counts Data
PCs were determined daily using a Sysmex XE210D.
Thrombocytopenia was considered present when the PC
was ,1506103/mm3 (8). A 10% range variation in PC was
established as acceptable for determining a stable measure-
ment. The prospectively collected PC data included the
following items: absolute PC on the day of ICU admission
(D0) and absolute PC during the first week of RRT on days
1, 3, 5 and 7 (D1, D3, D5 and D7, respectively).
The relative PC variation during the first week of RRT was
calculated as follows: relative PC between D1-D3 of
RRT= [(PC D3-PC D1/PC D1)]*100; relative PC between
D1-D5 of RRT= [(PC D5- PC D1/PC D1)]*100; relative PC
between D1-D7 of RRT= [(PC D7-PC D1/PC D1)]*100;
relative PC at the point of highest PC variation (nadir or
acme) = [(PC D3-PCD1 or PC D5-PCD1 or PC D7-PC D1)/PC
D1]*100, according to an individual’s variation time points.
The measured PCs were stratified as follows (10). The
absolute PCs on the first day of RRT were divided into
$1506103/mm3, 1002149.96103/mm3, 50299.96103/mm3
and ,506103/mm3. The relative PC variations were
classified as reduced, stable or increased over the D1-D3,
D1-D5 and D1-D7 assessment periods. The relative PC
reductions during the first week of RRT were divided into
$60%, 30% to 59.9%, 10% to 29.9% and ,10% over the D1-
D3, D1-D5 and D1-D7 assessment periods. The relative PC
reductions during the first week of RRT using the PC nadir
were divided into $60%, 30% to 59.9%, 10% to 29.9% or
#10% over the D1-D3; D1-D5 or D1-D7 assessment periods.
The hospital mortality rate was the outcome of interest.
Statistical analysis
A single data manager entered the data into a computer
database. Standard descriptive statistics were used to
describe the study population. Continuous variables are
presented as the mean¡SD or median (25–75% interquartile
range) and were compared using Student’s t-test or the chi-
squared test, as appropriate. Logistic regression analysis
was used to identify the factors associated with the hospital
mortality rate. Variables yielding p-values ,0.25 by the
univariate analysis and variables considered clinically
important were entered in a forward multivariate logistic
regression analysis. The results of both the uni- and
multivariate analyses were summarized by estimating the
odds ratios (ORs) and their respective 95% confidence
intervals (CIs). Possible interactions and collinear relation-
ships were tested. Discrimination was evaluated by calcu-
lating the area under the receiver operating characteristic
curve (AROC) (19). The Hosmer-Lemeshow goodness-of-fit
test was used to evaluate the model’s calibration (22). A
two-tailed p,0.05 was considered statistically significant.
& RESULTS
Characteristics of the study population
A total of 274 patients who developed AKI requiring RRT
during the first week of ICU admission were included in the
study. The mean age was 69¡16 years. The main cause of
AKI was sepsis (68%). At the time that dialysis was
indicated, the severity of the renal injury was classified
using the RIFLE criteria as follows: RIFLE-F = 143 (52.2%);
RIFLE-I = 59 (21.5%), and RIFLE-R= 72 (26.3%). The indica-
tions for RRT (the same patient could have more than one
simultaneously) were as follows: hypervolemia [150 (55%)],
metabolic acidosis [168 (61%)], hyperkalemia [24 (9%)],
dysnatremias [14 (5%)], azotemia [128 (47%)] and oligoa-
nuria [59 (22%)]. CRRT was the most common dialysis
modality, and it was prescribed in 220 patients (80.2%) with
hemodynamic or neurologic instability or severe metabolic
disorders. Anticoagulation was not prescribed for most RRT
procedures [244 patients (89%)]. LMW heparin was used in
all 30 patients (11%) who received anticoagulation on at
least one occasion. The patients’ main demographic and
clinical characteristics and the laboratory results are shown
in Table 1.
Outcome analysis
The ICU and hospital mortality rates were 58.4% and 62%,
respectively. The mean ICU and in-hospital lengths of stay
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were 14 days (range 8–31 days) and 22 days (range 11–44
days), respectively. In the univariate analysis, mechanical
ventilation, vasoactive drugs, poor chronic health status
(Knaus C and D) and co-morbidities (Charlson.1) were
significantly associated with a worse outcome (Table 2).
Platelet Counts Outcome Results
On D0 of the ICU admission, survivors had a significantly
higher mean PC than non-survivors [175.56103/mm3
(108.522596103/mm3) vs. 1486103/mm3 (8021416103/
mm3)] (p= 0.03). On D1 of RRT, 8.8% of patients already
had severe thrombocytopenia (PC ,506103/mm3). The
hospital mortality in this group was significantly higher
(87.5%, p= 0.014). During the first week of RRT, the
survivors had a significantly higher mean PC than the
non-survivors [D1 of RRT= 1786103/mm3 (113.522586103/
mm3) vs. 148.56103/mm3 (8322416103/mm3) (p=0.02); D3
of RRT= 1376103/mm3 (8222116103/mm3) vs. 97.56103/
mm3 (5221786103/mm3) (p= 0.001); D5 of RRT= 1296103/
mm3 (69.522186103/mm3) vs. 796103/mm3 (41.32139.56
103/mm3) (p= 0.001); D7 of RRT= 1566103/mm3 (95.92
2386103/mm3) vs. 88.56103/mm3 (4621666103/mm3) (p=
0.001)] (Figure 1).
To remove baseline individual PC variations during the
first week of RRT, relative PCs and relative PCs using the
observed main variation point (nadir or acme) were
calculated and analyzed. Reduced or stabilized relative
PCs were associated with a higher mortality rate (Table 3).
Similarly, a higher percentage of the relative PC reduction
during the first week of RRT was associated with a higher
hospital mortality rate. A PC reduction .60% was asso-
ciated with a worse outcome on D1-D3 (70.3%, p= 0.42), D1-
D5 (72.5%, p,0.001), D1-D7 (78.0%, p,0.001) and at the
nadir (82.5%, p,0.001). The results are shown in Table 3.
Table 1 - Patient demographics, clinical characteristics
and laboratory data (n= 274).a
Variables AKI (n = 274)
Age (years) 69¡16
Male gender 153 (55.8%)
Poor chronic health status (Knaus C or D) 99 (36.1%)
Charlson Co-morbidity Index (points) 3 (1–5)
Charlson Co-morbidity Index $1 point 230 (84%)
SAPS II (ICU admission, points) 46 (39–54)
SAPS II (ICU admission, probability of death, %) 36.9 (23–55)
SOFA on day 1 of RRT 8¡3.1
SOFA on day 1 of RRT (except for renal and
hematologic points)
6¡3.1
APACHE II (ICU admission, points) 21 ¡ 6
RIFLE at RRT decision
Risk 72 (26%)
Injury 59 (21%)
Failure 143 (52%)
Clinical admission 221 (81%)
Sepsis 186 (68%)
Mechanical ventilation 198 (72%)
Vasopressors 189 (69%)
Platelet counts
Platelet counts on ICU admission (x103/mm3) 150 (94–253)
,1506103/mm3 on first day of ICU [n (%)] 137 (50%)
,1506103/mm3 on first day of RRT [n (%)] 131 (48%)
,1506103/mm3 on at least one measurement [n (%)] 192 (70%)
Length of ICU stay (days) 14 (8–31)
Length of hospital stay (days) 22 (11–44)
Decision to withhold/withdraw treatment 36 (13.1%)
ICU mortality rate 160 (58.4%)
Hospital mortality rate 170 (62%)
aThe results are expressed as the mean¡standard deviation or median
(interquartile range); n =number of patients (%); RRT= renal
replacement therapy; ICU= intensive care unit; RIFLE =Risk, Injury,
Failure, Loss and End-Stage Renal Disease acute kidney injury severity
score; SOFA= sepsis-related organ failure assessment; SAPS II = Simplified
Acute Physiology Score.
Table 2 - Univariate analysis of patient characteristics associated with hospital mortality rate (n= 274).a
Variables Survivors n= 104 (38%) Non-Survivors n = 170 (62%) Odds Ratio (95% CI) p-value
Age (years) 63.4¡17.5 72.8¡14.2 1.04 (1.02–1.06) ,0.001
Male gender 54 (51.9%) 99 (58.3%) 1.2 (0.7–2.1) 0.30
Clinic admission 82 (78.9%) 139 (81.8%) 1.2 (0.6–2.2) 0.50
Sepsis 64 (61.5%) 122 (70.6%) 1.5 (0.9–2.6) 0.70
Mechanical ventilation 68 (65.5%) 130 (76.5%) 1.7 (1.0–2.9) 0.04
Vasoactive drugs 61 (58.7%) 128 (98.5%) 2.1 (1.2–3.6) 0.04
Poor chronic health status (Knaus C and D) 14 (13.5%) 85 (50.0%) 6.4 (3.9–12.7) 0.001
Co-morbidities (Charlson .1) 77 (74.0%) 153 (90.0%) 3.1 (1.6–6.1) 0.001
SAPS II (on first day of RRT) 41.6¡10.7 49.9¡10.6 1.08 (1.05–1.11) ,0.001
SOFA (without renal and hematologic points) 3.8¡3.0 5.4¡3.0 2.6 (1.8–3.7) ,0.001
Dialysis on the first day of ICU admission 82 (78.9%) 113 (66.5%) 0.5 (0.3–0.9) 0.02
aThe results are expressed as the mean¡standard deviation (SD) or median (interquartile range); n =number of patients (%); ICU= intensive care unit;
CI = confidence interval; SOFA= Sepsis-related Organ Failure Assessment; SAPS II = Simplified Acute Physiology Score.
Figure 1 - Box-plot of sequential platelet counts (PCs) during the
first week of renal replacement therapy (RRT). Survivors (n=104);
Non-survivors (n=170). Intensive care unit (ICU) admission (Day
0), p=0.03; Day 1 of RRT, p=0.02; Day 3, Day 5 and Day 7 of RRT,
p,0.001.
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Figure 2 shows the Kaplan–Meier survival curve using the
percentage of relative PC reduction at the nadir.
To evaluate the prognostic value of PCs in the study
population, two different models were built and entered
into the multivariate analysis. To avoid collinearity, each
model included a severity of illness score (SOFA) without
renal and hematologic points and a platelet variable (either
the reduction or stabilization of the relative PC or the
percentage of relative PC reduction) (Table 4).
& DISCUSSION
In this prospective study, we demonstrated that throm-
bocytopenia was significantly associated with a worse
outcome in dialytic AKI in the ICU and that sequential PC
analysis could be used as a prognostic tool in this
population.
Thrombocytopenia is one of the most common laboratory
findings in the ICU (5,21–22). In the present study, 50% of
patients already had PCs below 1506103/mm3 upon ICU
admission. Moreover, 48% of patients had thrombocytope-
nia on the first day of RRT, and 70% had at least one PC
measurement below 1506103/mm3 during the study.
Nonetheless, a PC ,506103/mm3 was observed in only 24
patients (8.8%) upon RRT initiation and in 40 patients (14%)
throughout the first week of RRT. Our data suggest that,
similar to the findings that have been described for the
general ICU population, in AKI patients requiring RRT,
thrombocytopenia occurs frequently, but severe thrombo-
cytopenia is unusual (23,24).
Lower PCs have been associated with higher ICU
mortality rates. Brogly et al. (7) reported that a PC of
,506103/mm3 on the first day in the ICU in patients with
severe community-acquired pneumonia was an indepen-
dent factor for hospital mortality. Similarly, Vandershueren
et al. (8) reported that thrombocytopenia occurring during
ICU admission was an independent marker of illness
severity and was associated with a higher hospital mortality
rate. In AKI patients, thrombocytopenia on the first day of
RRT has been associated with a worse outcome (14).
Similarly, in the present study, severe thrombocytopenia
(a PC ,506103/m m3) on D1 of RRT was associated with a
significantly higher in-hospital mortality rate compared
with the whole study population (87.5% vs. 62%).
In healthy individuals, the consistency and reproduci-
bility of PCs are well established (25,26). The normal
baseline PC range is 150 to 3506103/mm3 for the general
population, and the amount of variation for a given
individual on sequential evaluations is small (approxi-
mately 606103/mm3) (23). However, in the ICU setting,
the PC variation over time behaves as a more sensitive
variable than the absolute PC to distinguish survivors and
non-survivors (27). To minimize the basal individual PC
differences, we sequentially analyzed the relative PCs and
showed that a reduced relative PC during the first week of
RRT was associated with a higher mortality. Nevertheless,
Table 3 - Hospital mortality rate according to platelet count variations and reductions.
Stratification of
relative platelet
counts D1-D3 (n= 274) D1-D5 (n = 248) D1-D7 (n = 209)
Largest relative platelet count
variation* (n= 274)
Patients n
(%)
Mortality
rate (%)
Patients n
(%)
Mortality
rate (%)
Patients n
(%)
Mortality
rate (%)
Patients n
(%)
Mortality
rate (%)
Variation D
Reduction ,10% 168 (61.3) 65.5 180 (72.6) 67.8 128 (61.3) 64.1 135 (49.3) 70.4
Stable 60 (21.9) 63.3 31 (12.5) 41.9 27 (12.9) 59.3 59 (21.5) 67.8
Increase .10% 46 (16.8) 47.8 37 (14.9) 32.4 54 (25.8) 29.6 80 (29.2) 43.8
P-value p=0.089 p,0.001 p,0.001 p,0.001
ReductionDD
Relative platelet count nadir**
(n = 274)
$60% 37 (13.5) 70.3 51 (20.6) 72.5 41 (19.6) 78.0 23 (8.4) 82.6
30–59.9% 75 (27.4) 62.7 81 (32.7) 65.4 56 (57.1) 57.1 53 (19.3) 69.8
10–29.9% 56 (20.4) 66.1 48 (19.4) 66.7 31 (14.8) 58.1 59 (21.5) 66.1
,10% 106 (38.7) 56.6 68 (36.8) 36.8 81 (38.8) 39.5 139 (50.7) 54.0
P-value p=0.42 p,0.001 p,0.001 p,0.001
PC=platelet count; RRT= renal replacement therapy; Days (D) 1,3,5,7 of RRT; D=Relative PC variation=PC (D3-D1)/D16100; PC (D5-D1)/D16100; PC (D7-
D1)/D1]6100 (results are shown as reduction. 10%, stable and increase .10% compared to D1); * = largest relative PC variation= relative PC (nadir or
acme at D1-D3 or D1-D5 or D1-D7); DD=Relative PC reduction = PC (D3-D1)/D16100; PC (D5-D1)/D16100; PC (D7-D1)/D1]6100 (results are shown as
percentages); ** =Nadir = Relative PC reduction at the point of the largest relative PC reduction at D1-D3 or D1-D5 or D1-D7.
Figure 2 - Kaplan-Meier curve of survival outcomes following
hospital admissions of acute kidney injury patients in the
intensive care setting according to percentage of relative
platelet count (PC) at the nadir during the first week of renal
replacement therapy (RRT). A PC reduction.60% was associated
with worse outcomes (p,0.001).
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this result was only statistically significant after D5 of RRT.
Moreau et al. (10) recently described the profile of PCs
in ICU patients. The authors noted that the drop in PCs
from the normal range occurred during the first three days
in the ICU, and the nadir was observed on D3 in the
survivors and D4 in the non-survivors. This result may
have been a confounding factor in our results. However,
when we minimized this possible individual PC variation
over time, performing the analysis based on the point of
largest PC variation (nadir or acme), the relative PC
reduction or stabilization was significantly associated with
a higher hospital mortality rate. Similarly, a higher relative
PC reduction was associated with a worse outcome,
particularly when the reduction was over 60%. Our results
corroborate the results observed in the literature for general
ICU patients (10).
In the present study, the patients who presented a
bimodal PC pattern with an increase in PC after developing
thrombocytopenia had a more favorable prognosis. Our
data corroborated the reports of Akca et al. (24) and
Nijsten et al. (27) who identified the same bimodal PC
pattern more frequently in critically ill survivors than in
non-survivors.
The sequential evaluation of PCs in the present study,
similarly to the findings for ICU patients but different from
the results observed for end-stage renal disease patients,
indicate that PC variation is an independent predictor of the
hospital mortality rate in patients with AKI requiring RRT
in the ICU and performs better than many prognostic
markers in AKI (7–13,28). However, we would reiterate that
no prognostic score should be used for predictions about
individual patients, although using a simple and accessible
measurement such as PC may help in clinical decision
making to improve resource allocation in the ICU and in
stratifying AKI patients in need of RRT in clinical trials.
As for the limitations of our analysis, we did not measure
PCs in the dialysis circuit nor did we routinely quantify the
heparin-induced antibodies. Previous reports have shown
that small continuous platelet losses make a cumulative
contribution to the thrombocytopenia observed in dialyzed
AKI patients in the ICU (29). However, these losses seem to
be related to the in vivo use of cuprophane membranes and
to the non-albumin content of dialysis solutions when tested
in artificial systems (29). Despite the negative correlation
between the blood flow rate and platelet loss in CRRT, Docci
et al. reported that platelet losses in RRT can be minimized
by increasing the blood flow rate and that such losses can be
avoided almost entirely when the blood flow rate is
maintained .200 ml/min during a dialysis procedure
(30,31). In the present study, all of the patients underwent
RRT, and PS membranes were prescribed for all of the
procedures. In addition, we maintained a 200-ml/min blood
flow rate even during CRRT. LMW heparin was prescribed
in 11% of cases, and no heparin-induced thrombocytopenia
was suspected or confirmed.
In conclusion, the PCs upon ICU admission and at the
beginning of RRT as well as its sequential evaluation during
the first week of RRT have prognostic value in AKI patients
requiring RRT.
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